NOVO NORDISK FEMCARE AG – Trademark Portfolio

Entity Type: 03

NOVO NORDISK FEMCARE AG holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ACTIVELLA. The owner is based in CH-8050 ZURICH.

ANDREASSTRASSE 15

CH-8050 ZURICH , CH

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NOVO NORDISK FEMCARE AG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does NOVO NORDISK FEMCARE AG have?

NOVO NORDISK FEMCARE AG has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 3 cancelled.

What trademark classes does NOVO NORDISK FEMCARE AG file in?

NOVO NORDISK FEMCARE AG files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are NOVO NORDISK FEMCARE AG's most well-known trademarks?

NOVO NORDISK FEMCARE AG's registered trademark portfolio includes well-known marks such as ACTIVELLA. These are among 1 currently registered trademark in the portfolio.

What is NOVO NORDISK FEMCARE AG's trademark registration success rate?

NOVO NORDISK FEMCARE AG has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.